Search for an ETF or holding
MARVEL BIOSCIENCES CORP (MRVL.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 16 million CAD (micro-cap).
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.